Nitrofurantoin Glenmark Pharmaceuticals Europe

Nitrofurantoin, the active ingredient in Nitrofurantoin Glenmark Pharmaceuticals Europe, is a nitrofuran antibiotic presented as an oral tablet for oral use. It treats uncomplicated urinary tract infections in adult patients. GNH USA supplies Nitrofurantoin Glenmark Pharmaceuticals Europe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitrofurantoin is a nitrofuran antibiotic used to manage infections of the urinary tract. - Uncomplicated urinary tract infection: eradicates susceptible uropathogens and resolves symptoms. - Acute cystitis: provides bactericidal activity to clear infection of the bladder. - Prophylaxis of recurrent urinary tract infection: reduces the frequency of future infections when taken regularly.

Nitrofurantoin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Loss of appetite: reduced desire to eat. - Headache: transient cranial discomfort. - Diarrhoea: loose stools, usually self‑limiting. - Metallic taste: transient alteration of taste perception. - Mild skin rash: limited erythema or itching.

Serious or Rare Side Effects: - Pulmonary toxicity: interstitial pneumonitis or fibrosis, requiring immediate medical attention. - Hepatic injury: elevated liver enzymes or hepatitis. - Severe allergic reaction: anaphylaxis with rash, swelling, and airway compromise. - Hemolytic anemia in G6PD deficiency: rapid drop in red blood cells. - Peripheral neuropathy: numbness or tingling in extremities. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin detachment.

Before prescribing Nitrofurantoin, clinicians should consider several safety factors. - Renal function assessment: avoid use when creatinine clearance is <60 mL/min. - Pregnancy safety: category B, generally acceptable but avoid in late third trimester. - Breastfeeding: monitor infant for gastrointestinal upset. - G6PD deficiency: contraindicated due to risk of hemolysis. - Monitor for pulmonary symptoms: discontinue if cough or dyspnoea develop. - Store below 25°C: keep in the original pack, protect from moisture.

Nitrofurantoin can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Antacids containing magnesium or aluminium: markedly reduce absorption. - Probenecid: decreases renal excretion, increasing plasma levels.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Diuretics: can affect renal clearance, necessitating dose adjustment. - NSAIDs: combined use may impair renal function, especially in susceptible patients.